These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

958 related items for PubMed ID: 31757263

  • 1. Adjunctive memantine for opioid use disorder treatment: A systematic review.
    Elias AM, Pepin MJ, Brown JN.
    J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
    [Abstract] [Full Text] [Related]

  • 2. Maintenance medication for opiate addiction: the foundation of recovery.
    Bart G.
    J Addict Dis; 2012 Dec; 31(3):207-25. PubMed ID: 22873183
    [Abstract] [Full Text] [Related]

  • 3. Buprenorphine for managing opioid withdrawal.
    Gowing L, Ali R, White JM, Mbewe D.
    Cochrane Database Syst Rev; 2017 Feb 21; 2(2):CD002025. PubMed ID: 28220474
    [Abstract] [Full Text] [Related]

  • 4. A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence.
    Bisaga A, Sullivan MA, Cheng WY, Carpenter KM, Mariani JJ, Levin FR, Raby WN, Nunes EV.
    Drug Alcohol Depend; 2011 Dec 01; 119(1-2):e23-9. PubMed ID: 21715107
    [Abstract] [Full Text] [Related]

  • 5. The Effect of Adding Memantine to Clonidine in Reducing Withdrawal Symptoms in Opioid-Dependent Patients: A Double-Blind Randomized Controlled Trial.
    Kheirabadi G, Najafian N, Khodadadi F.
    J Clin Psychopharmacol; 2011 Dec 01; 41(6):644-649. PubMed ID: 34559090
    [Abstract] [Full Text] [Related]

  • 6. CE: Acute Pain Management for People with Opioid Use Disorder.
    Broglio K, Matzo M.
    Am J Nurs; 2018 Oct 01; 118(10):30-38. PubMed ID: 30211703
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Update on pharmacotherapy for treatment of opioid use disorder.
    Ayanga D, Shorter D, Kosten TR.
    Expert Opin Pharmacother; 2016 Dec 01; 17(17):2307-2318. PubMed ID: 27734745
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Medication Treatment of Opioid Use Disorder.
    Bell J, Strang J.
    Biol Psychiatry; 2020 Jan 01; 87(1):82-88. PubMed ID: 31420089
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
    Chalhoub RM, Kalivas PW.
    Drugs; 2020 Oct 01; 80(15):1509-1524. PubMed ID: 32776315
    [Abstract] [Full Text] [Related]

  • 19. A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.
    Bisaga A, Sullivan MA, Glass A, Mishlen K, Carpenter KM, Mariani JJ, Levin FR, Nunes EV.
    J Subst Abuse Treat; 2014 Oct 01; 46(5):546-52. PubMed ID: 24560438
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.